chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Feeling abnormal, Nausea
Clinical narrative: Feeling extremely out of it; light headed/dizzy; nausea; abdominal cramping; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6202), via an unspecified route of administration on Left arm on 05Mar2021 at 12:30 PM (at the age of 51-year-old) as a single dose for COVID-19 immunization. The patient had medical history included hypertension and hypothyroidism. Concomitant medications included Labetalol, Nifedipine, Levothyroxine and Amoxicillin (all received within two weeks of vaccination). Patient previously took Doxycycline and had allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Mar2021, patient experienced, feeling extremely out of it, lightheaded/dizzy, nausea and abdominal cramping. Patient did not receive any treatment for the events. Outcome of all the events were Not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes simplex reactivation
Clinical narrative: HSV1 outbreak; This is a spontaneous report from a contactable consumer (Patient).  A 37-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), an unspecified route of administration, administered in Arm Left on 02Mar2021 at 16:00 (Batch/Lot Number: EM 6022) as 1st dose, single dose for covid-19 immunization. Medical history included herpes simplex from 2004 to an unknown date. The other concomitant medication within two weeks included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and probiotics. The patient did not take any other vaccine in four weeks. The patient did not had Covid prior vaccination and not tested for Covid post vaccination.On 04Mar2021, the patient had Herpes simplex virus type I reactivation. It was reported that patient had contracted HSV1 around 2004 and he had not any outbreak since 2017. It was reported that two days after having the first dose of the Covid vaccine patient had an HSV1 outbreak. The patient did not receive any treatment for event. The outcome of event was not recovered.  No follow up attempts are possible. No Further information is excepted.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: The only adverse event work on sore arm other than that everything is fine; This is a spontaneous report from a contactable consumer (patient, self-reported). A 65-year-old male patient (age at vaccination: 65 year) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6200 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 05Mar2021 at 02:30 PM, as a single dose for COVID-19 immunization at doctor's office/urgent care. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that the only adverse event work on sore arm other than that everything was fine on 05Mar2021 at 04:30 PM. The patient did not receive any treatment for the event. Outcome of the event was recovered on an unknown date.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: Dizziness and light-headedness; Fatigue; Headache; Sore muscles; This is a spontaneous report from a non-contactable consumer or other non hcp. A 48 unknown unit female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration, administered in left arm on 06Mar2021 (Batch/Lot Number: EN6198) as 1st dose, single for covid-19 immunization. The patient had no medical history and no concomitant medications. The patient had no known allergies. On 06Mar2021, after the vaccination the patient experienced Dizziness and light-headedness, Fatigue, Headache, Sore muscles. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Vaccination site pain
Clinical narrative: injection site pain; weakness; This is a spontaneous report from a non-contactable pharmacist. A male patient of unspecified age received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine,Formulation: Solution for injection,Lot Number and Expiry date:Unknown), via an unspecified route of administration on Feb2021 as 1ST DOSE, SINGLE for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date in Feb2021, post vaccination the patient experienced injection site pain and weakness. The patient was not treated with any medication for the events. The outcome of the events was reported as recovered on an unknown date in 2021.  No follow-up attempts are possible. No information about lot/batch number cannot been obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site; This is a spontaneous report from a contactable Other HCP (Patient). A 69-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in left arm on 04Mar2021 at 04:30 PM as single dose for COVID-19 immunisation. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EM9809), via an unspecified route of administration, administered in left arm on 11Feb2021 at 11:00 AM as single dose for COVID-19 immunisation. The patient medical history included high blood pressure and had unspecified allergies. Concomitant medications included Losartan. Patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID prior vaccination. On 05Mar2021 at 07:00 AM (next day after vaccination), patient experienced soreness at injection site. The patient did not receive any treatment for the events. Since the vaccination, patient had not been tested for COVID-19. The outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Body mass index, Chills, Fungal infection, Headache
Clinical narrative: Headaches 2 weeks after second dose with auras and migraines triggered; Headaches 2 weeks after second dose with auras and migraines triggered; Chills without fever; general malaise; yeast infection; This is a spontaneous report from a contactable consumer or other non hcp. A 33-years-old female patient received (BNT162B2, Solution for injection, Batch/Lot Number: en6200), second dose via an unspecified route of administration, administered in Arm Left on 21Feb2021 at 14:45 (at the age of 33 years old) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included body mass index from an unknown date and unknown if ongoing other medical history-31 BMI, asthma from an unknown date and unknown if ongoing other medical history-Asthma, blood cholesterol from an unknown date and unknown if ongoing other medical history-Cholesterol, migraine from an unspecified date and unknown if ongoing other medical history-Migraines, anxiety from an unspecified date and unknown if ongoing other medical history-Anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any known allergic reactions. Concomitant medications included vitamin d3 taken for an unspecified indication, start and stop date were not reported; valaciclovir hydrochloride taken for an unspecified indication, start and stop date were not reported; sumatriptan taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: el9264) via an unspecified route of administration, administered in Arm Left on 31Jan2021 at 15:30 (at the age of 33 years old) as 1ST DOSE, SINGLE for covid-19 immunisation. On 22Feb2021 at 14:00 the patient experienced headaches 2 weeks after second dose with auras and migraines triggered headaches, chills without fever, general malaise, yeast infection. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Migraine with aura
Clinical narrative: Headaches 2 weeks after second dose with auras and migraines triggered; Headaches 2 weeks after second dose with auras and migraines triggered; Chills without fever; general malaise; yeast infection; This is a spontaneous report from a contactable consumer or other non hcp. A 33-years-old female patient received (BNT162B2, Solution for injection, Batch/Lot Number: en6200), second dose via an unspecified route of administration, administered in Arm Left on 21Feb2021 at 14:45 (at the age of 33 years old) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included body mass index from an unknown date and unknown if ongoing other medical history-31 BMI, asthma from an unknown date and unknown if ongoing other medical history-Asthma, blood cholesterol from an unknown date and unknown if ongoing other medical history-Cholesterol, migraine from an unspecified date and unknown if ongoing other medical history-Migraines, anxiety from an unspecified date and unknown if ongoing other medical history-Anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any known allergic reactions. Concomitant medications included vitamin d3 taken for an unspecified indication, start and stop date were not reported; valaciclovir hydrochloride taken for an unspecified indication, start and stop date were not reported; sumatriptan taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: el9264) via an unspecified route of administration, administered in Arm Left on 31Jan2021 at 15:30 (at the age of 33 years old) as 1ST DOSE, SINGLE for covid-19 immunisation. On 22Feb2021 at 14:00 the patient experienced headaches 2 weeks after second dose with auras and migraines triggered headaches, chills without fever, general malaise, yeast infection. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Raynaud's phenomenon
Clinical narrative: Sore arm both vaccines.; experienced Raynauds disease in my right hand on 3 fingers; This is a spontaneous report from a contactable consumer (patient, self-reported).  A 34-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6203 and Expiry date: not provided), dose 2 via an unspecified route of administration, in the left arm, on 20Feb2021 at 16:00, as single dose for COVID-19 immunisation. The patient's medical history included hashimotos disease. The patient was allergic to shellfish allergy and bees. Concomitant medications included levothyroxine sodium (SYNTHROID) and multivitamin. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN9581 and Expiry date: not provided), dose 1 via an unspecified route of administration, in the left arm, on 29Jan2021 at 18:45, as single dose for COVID-19 immunisation and got the sore pain. The patient did not receive any other vaccine in four weeks. The patient did not have COVID-19 prior to vaccination. On 23Feb2021 17:00, the patient experienced sore arm both vaccines and raynaud's disease in her right hand on 3 fingers. The patient did not receive any treatment for adverse events. The patient did not receive any other vaccine in four weeks. The patient did not test for COVID-19 post vaccination. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza
Clinical narrative: headache; flu; This is a spontaneous report from a contactable consumer (reporting for wife).   A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 13Feb2021 (Batch/Lot number was not reported), vaccination age of 68 years, as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  After vaccination the patient experienced headache and flu (non-serious) on an unspecified date with outcome of unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Erythema, Fatigue
Clinical narrative: Red face; Chills; A 100 fever; Diarrhea; Achy; Nausea; Tired; This is a spontaneous report was received from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206 and expiry date: unknown), via an unspecified route of administration on an unspecified date as unknown dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got the Pfizer Covid shot on Friday at 1 o clock in the evening. The patient woke up on an unspecified date (reported as Saturday) and the patient experienced red face, chills, a 100 fever, diarrhoea, achy, nausea and tired. The patient wanted to know was that expected. The patient underwent lab tests and procedures which included body temperature 100. Outcome of the events was unknown.  Reason of delay: Daily spike of incoming calls due to COVID19 vaccine.  No follow up attempts are possible. No further information is expected
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Red face; Chills; A 100 fever; Diarrhea; Achy; Nausea; Tired; This is a spontaneous report was received from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206 and expiry date: unknown), via an unspecified route of administration on an unspecified date as unknown dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got the Pfizer Covid shot on Friday at 1 o clock in the evening. The patient woke up on an unspecified date (reported as Saturday) and the patient experienced red face, chills, a 100 fever, diarrhoea, achy, nausea and tired. The patient wanted to know was that expected. The patient underwent lab tests and procedures which included body temperature 100. Outcome of the events was unknown.  Reason of delay: Daily spike of incoming calls due to COVID19 vaccine.  No follow up attempts are possible. No further information is expected
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate abnormal
Clinical narrative: After second shot, rapid heart rate within 30 minutes, lasted off and on through the second day; Bouts of dizziness; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received second dose of BNT162B2 (COVID 19, Pfizer, Solution for injection) via an unspecified route of administration, administered to her left arm on 06Mar2021 10:45 AM (at age of 70-year-old) (Lot unknown reason: Misplaced/discarded) as single dose for Covid-19 immunization. Facility type vaccine: School or Student Health Clinic. The patient's medical history included atrial fibrillation and congestive heart failure (CHF), catheter ablation on 21Apr2021 (successfully cured) and implanted heart monitor. No Covid tested prior or post vaccination. No known allergies reported. Concomitant medications were reported as none. The patient previously took first dose of BNT162B2 (COVID 19, Pfizer, Solution for injection) via an unspecified route of administration, administered to her left arm on 13Feb2021 03:00 PM as single dose for Covid-19 immunization and experienced rapid heart rate, 99, palpitations, high blood pressure within two hours after first shot (on 13Feb2021 05:00 PM) which lasted about 36 hours (treatment received: No). Second shot, rapid heart rate within 30 minutes, lasted off and on through the second day. Bouts of dizziness started about 12 hours after injection, still experiencing off and on. Heart rate issues recorded on her watch. The patient did not receive any treatment in response to the events. Outcome of the events was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot been obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in jaw
Clinical narrative: Numbness feeling on left side of body; sharp pain in jaw; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old female patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot Number: En8201), dose 1 via an unspecified route of administration, administered on Arm Left on 25Feb2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant was not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was reported that, on 25Feb2021, The patient experienced numbness feeling on left side of body, sharp pain in jaw. No treatment was received for the events. The outcome of events was "recovered".
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: Patchy clusters or individual spots. Last 2-3 weeks.; This is a spontaneous report from a contactable female consumer (patient reported for herself). A 74-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 74-year-old) at a 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive other vaccines prior to the COVID vaccine within 4 weeks. The patient experienced patchy clusters or individual spots last 2-3 weeks on an unspecified date. AE resulted in doctor or other healthcare professional office/clinic visit. The patient had not tested for COVID-19 post vaccination. The patient did not receive any treatment for the events. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia oral
Clinical narrative: tingling in the tip of the tongue halfway; redness in face and forehead; This is a spontaneous report from a contactable consumer reporting for herself. A 58-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot number and expiration date were not reported) via an unspecified route of administration, administered in left arm on 26Feb2021 11:00 as SINGLE DOSE for COVID-19 immunization. The patient had known allergies (unspecified). Concomitant medication(s) included hydrocortisone cream; clobetasol cream 0.05 (unit not reported); and bacitracin zinc, neomycin sulfate, polymyxin B sulfate (NEOSPORIN). The patient did not receive any other vaccine in four weeks prior to COVID vaccination. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that on 26Feb2021 11:00, the patient had tingling in the tip of the tongue halfway, redness in face and forehead. Therapeutic measures were taken as a result of event; treatment included Benadryl. The outcome of the events reported as Recovered with lasting effects (Recovered/Resolved with Sequel).  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer, (patient).   A 34-year-old female patient (non-pregnant) received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: EN9581, Expiration date: Unknown), via an unspecified route of administration in the left arm on 29Jan2021 at 18:45 as 1st dose, single dose for COVID-19 immunization. Medical history included Hashimotos Disease known allergies Shellfish, bees. Concomitant medications included levothyroxine sodium [SYNTHROID], multivitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, patient experienced sore arm. The patient did not receive any treatment for reported event. The outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Headache, Pain
Clinical narrative: Liquid diarrhea; Soreness; headache; brain fog; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female consumer received first bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: En6199), via an unspecified route of administration, administered in right arm on 05Mar2021 03:45 PM (at the age of 53-year-old) at single dose for COVID-19 immunization at the hospital. The patient medical history included Bc 2017; thyroid 2020; hbp 2010. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications in two weeks included tamoxifen, levothyroxine sodium (SYNTHROID) and Lisinopril-all medications taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient did not received other vaccines. On an unspecified date the patient experienced liquid diarrhea, 02hours after continued soreness, headache and brain fog. The patient did not received any treatment for the adverse events. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swelling, Swelling face
Clinical narrative: Left side neck & jaw lymphadenopathy and swelling; Left side neck & jaw lymphadenopathy and swelling; Left side neck & jaw lymphadenopathy and swelling; This is a spontaneous report from a contactable consumer (patient). A 54-years-old non-pregnant female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number not reported, patient was not pregnant and 54-years-old at the time of vaccination), via an unspecified route of administration in Arm Left on 01Mar2021 at 15:00 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced left side neck & jaw lymphadenopathy and swelling. reported that patient not received other vaccine in four weeks, reported that left arm injection site is normal, no treatment received for AE. Patient had not COVID prior vaccination and not tested COVID post vaccination. Reported that NKDA (No Known Drug Allergy). The outcome of reported events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: One inch long raised red spot a few inches below left collarbone (roughly 3 inches in from armpit).; This is a spontaneous report from a contactable consumer (Patient). A 36-year-non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6198) via an unspecified route of administration, administered in left arm on 03Mar2021 at 17:00 (at the age of 36-years-old) as single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications in 2 weeks of vaccination. Patient do not have allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history was none. Concomitant medications were not reported. On 04Mar2021 (next day of vaccination), patient experienced one inch long raised red spot a few inches below left collarbone (roughly 3 inches in from armpit). Patient had not received any treatment for the events. The patient was not tested for COVID-19 since the vaccination. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Cough, Gout, Insomnia
Clinical narrative: Fever of 100.4 degree; I was not able to really sleep I kept waking up; feet hurting; Body aches; having a lot of phlegm in the back of my throat / coughing up a lot of phlegm; having a lot of phlegm in the back of my throat / coughing up a lot of phlegm; Back hurting; Pain in my joints in my arms and my elbow; Pain in my joints in my arms and my elbow; Pain in my joints in my arms and my elbow; I still have this 'throbbing' (not clarified further) in my big toe that will not go away like I'm like in extreme pain in my right foot in my big toe.; I feel like this is gout or something it's driving me crazy, because my big toe is hurting so bad; I'm like in extreme pain in my right foot in my big toe. But, the other issue that I was dealing with is the fact that, it was in my left foot and then it went to my right foot; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 47-years-old female patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration, administered in Arm Left on an unspecified date around 2 O'clock in the afternoon (Batch/Lot Number: EN6206) as unknown, single dose for covid-19 immunisation. Medical history included multiple sclerosis. Concomitant medications included patient take medication for her thyroid and she also take an infusion for her multiple sclerosis. She also stated that she had blood work in the last 3 weeks in February 12th may be. On an unknown date when patient got home, she experienced a fever of 100.4 degree. She started drinking some water to bring the temperature down she took 3 Tylenol (as an event treatment) to bring the temperature down and I finally dropped the temperature down to 98.7. further, last night she did not have and she was not able to really sleep and kept waking up, she did not have chest pains or anything like that, but last night her feet started having issues as her feet hurting, her big toe was throbbing which she was not clarified and also had body aches. In morning, patient started having a lot of phlegm in the back of her throat, had coughing up a lot of phlegm. she took a Benadryl and, also took two more Tylenol, because she started having body aches again and Tylenol was not helping her alone because of lot of pain, her back hurting and started having pain in her joints, arms, and elbow. Patient still experienced throbbing (not clarified further) in her big toe that would not go away like in extreme pain in her right foot and in big toe. It was reported that patient had other issue that she was dealing with her left foot and then it went to her right foot which she did not understand why. The outcome of all events was reported as unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Productive cough, Pyrexia
Clinical narrative: Fever of 100.4 degree; I was not able to really sleep I kept waking up; feet hurting; Body aches; having a lot of phlegm in the back of my throat / coughing up a lot of phlegm; having a lot of phlegm in the back of my throat / coughing up a lot of phlegm; Back hurting; Pain in my joints in my arms and my elbow; Pain in my joints in my arms and my elbow; Pain in my joints in my arms and my elbow; I still have this 'throbbing' (not clarified further) in my big toe that will not go away like I'm like in extreme pain in my right foot in my big toe.; I feel like this is gout or something it's driving me crazy, because my big toe is hurting so bad; I'm like in extreme pain in my right foot in my big toe. But, the other issue that I was dealing with is the fact that, it was in my left foot and then it went to my right foot; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 47-years-old female patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration, administered in Arm Left on an unspecified date around 2 O'clock in the afternoon (Batch/Lot Number: EN6206) as unknown, single dose for covid-19 immunisation. Medical history included multiple sclerosis. Concomitant medications included patient take medication for her thyroid and she also take an infusion for her multiple sclerosis. She also stated that she had blood work in the last 3 weeks in February 12th may be. On an unknown date when patient got home, she experienced a fever of 100.4 degree. She started drinking some water to bring the temperature down she took 3 Tylenol (as an event treatment) to bring the temperature down and I finally dropped the temperature down to 98.7. further, last night she did not have and she was not able to really sleep and kept waking up, she did not have chest pains or anything like that, but last night her feet started having issues as her feet hurting, her big toe was throbbing which she was not clarified and also had body aches. In morning, patient started having a lot of phlegm in the back of her throat, had coughing up a lot of phlegm. she took a Benadryl and, also took two more Tylenol, because she started having body aches again and Tylenol was not helping her alone because of lot of pain, her back hurting and started having pain in her joints, arms, and elbow. Patient still experienced throbbing (not clarified further) in her big toe that would not go away like in extreme pain in her right foot and in big toe. It was reported that patient had other issue that she was dealing with her left foot and then it went to her right foot which she did not understand why. The outcome of all events was reported as unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Muscle pain; Chills; Not feeling good; I had some 100.4 to 100.6, I still have a temperature; fever most of the day; dull headache; Feeling very tired; This is a spontaneous report from a contactable consumer (patient).   A 75-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 07Mar2021 08:30 (Batch/Lot Number: EN6199) at the age of 75 years, as single dose for covid-19 immunisation.  Medical history included thyroid disorder. Concomitant medication included levothyroxine taken for thyroid disorder, start and stop date were not reported.   The patient experienced feeling very tired (non-serious) on 07Mar2021 20:00 with outcome of unknown, I had some 100.4 to 100.6, I still have a temperature; fever most of the day (non-serious) on 08Mar2021 with outcome of not recovered , dull headache (non-serious) on 08Mar2021 with outcome of unknown, muscle pain (non-serious) on an unspecified date with outcome of unknown , chills (non-serious) on an unspecified date with outcome of unknown , not feeling good (non-serious) on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included antibody test: unknown results on unknown date; body temperature: 100.4 to 100.6 on 08Mar2021.   No follow-up attempts are needed; No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pyrexia
Clinical narrative: Muscle pain; Chills; Not feeling good; I had some 100.4 to 100.6, I still have a temperature; fever most of the day; dull headache; Feeling very tired; This is a spontaneous report from a contactable consumer (patient).   A 75-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 07Mar2021 08:30 (Batch/Lot Number: EN6199) at the age of 75 years, as single dose for covid-19 immunisation.  Medical history included thyroid disorder. Concomitant medication included levothyroxine taken for thyroid disorder, start and stop date were not reported.   The patient experienced feeling very tired (non-serious) on 07Mar2021 20:00 with outcome of unknown, I had some 100.4 to 100.6, I still have a temperature; fever most of the day (non-serious) on 08Mar2021 with outcome of not recovered , dull headache (non-serious) on 08Mar2021 with outcome of unknown, muscle pain (non-serious) on an unspecified date with outcome of unknown , chills (non-serious) on an unspecified date with outcome of unknown , not feeling good (non-serious) on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included antibody test: unknown results on unknown date; body temperature: 100.4 to 100.6 on 08Mar2021.   No follow-up attempts are needed; No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: I was extremely fatigued; had body aches and a headache; had body aches and a headache; This is a spontaneous report from a contactable consumer (patient). A 46-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: En6202) via an unknown route of administration in left arm on 24Feb2021 as single dose for covid-19 immunization. The patient's concomitant medications were not reported. Medical history included hypothyroidism. Previously patient received first dose of BNT162B2, (solution for injection, Batch/Lot Number: EI9269) in left arm via an unknown route of administration on 03Feb2021 at 05:15 pm as single dose for covid-19 immunization. The vaccine was administered at workplace clinic. Patient was neither diagnosed with covid prior vaccination nor tested with covid post vaccination. There were no known allergies. On 25Feb2021 at 06:00 am, the patient was extremely fatigued, had body aches and a headache about 12 hours after second dose. No treatment was received for the events. The outcome of the events was resolved approximately on unknown date in 2021.  No follow-up attempts were possible. No further information was expected.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: I felt real kind of crummy a little bit like I was catching cold or something; This is a spontaneous report from a contactable consumer (patient). This contactable male patient of unspecified age reported that he received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6198) via an unspecified route of administration on 27Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient did not have any side effect after vaccination and then on Wednesday of this previous week which would be third and of course. On an unspecified date, the patient felt real kind of crummy, a little bit like he was starting to have a catching cold or something you know and his wife has cancer and everything and so he had two antibiotics tablets (unspecified medications) from a year ago and took them because he did not think they were the side effects of the vaccination. So, he took them and feels fine now. His question was that he took them two antibiotic on Thursday and was that going to affect his first shot (COVID-19 Vaccine) that he had. Treatment was received for the event reported. Outcome of event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Vaccination site pain
Clinical narrative: severe chills; severe soreness in shot area; lethargic; This is a spontaneous report from a contactable other HCP. A 60-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EM9810), via an unspecified route of administration, administered in Left Arm on 10Feb2021 as single dose for (at the age of 60-year-old) covid-19 immunization. Medical history included arrhythmia neonatal, thyroid disorder, gout and umbilical hernia. Other medical history reported as tachy-Brady syndrome, thyroid, gout, umbilical hernis. The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior vaccination and post vaccination, patient had tested with covid 19. No known allergies reported for the patient. Concomitant medication(s) included levothyroxine sodium (SYNTHROID); allopurinol (ALLOPURINOL); and digoxin (DIGITEK). These Other medications are administered in two weeks. On an unspecified date the patient experienced severe chills, severe soreness in shot area and lethargic. No treatment received for the event. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: slight rash; This is a spontaneous report from a contactable consumer or other non-HCP. An 84-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration (at the age of 84-years-old) on 06Feb2021 as first dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced slight rash. The patient received her second shot of Pfizer last Saturday, 27Feb2021 and before that she received her first shot 06Feb2021. The reason of her calling is she happened to read only today the literature they gave her. And after the first shot, she did experience a slight rash. She went to her doctor who did not seem concerned about it. she got her second shot, she still has some of that a little bit more and she was just reading that you should report a rash. It is blistered slightly, and it is a little itchy, but it is not overwhelming that she thought she should pass it and tell. And she wanted to know if an Epsom salt bath okay to take. she would like to take an Epsom salt bath. It is not medication. It is a batch for joints or skin to soothe it. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia
Clinical narrative: Patient experienced chills; weakness; mild fever within 24 hrs from getting a second shot of vaccine; This is a spontaneous report from a contactable consumer. This unspecified age and gender consumer (Patient) reported that received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. On an unspecified date the patient experienced chills, weakness and mild fever within 24hours from getting a second shot of vaccine.  The patient had not took any further medications, the fever normalized within 12hours. The patient did not received any treatment for the adverse events. The outcome of events was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: After receiving the second dose of the Pfizer vaccine reported fevers and muscle pains; After receiving the second dose of the Pfizer vaccine reported fevers and muscle pains; This is a spontaneous report received from a non-contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient received the second dose of the Pfizer vaccine and experienced fevers and muscle pains on an unspecified date and adverse events was mentioned during a casual conversation. The outcome of events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a Spontaneous report from a Pfizer- sponsored program. A contactable consumer (Patient, Self-reported). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 05Mar2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reportedly, Patient received 1st dose of covid vaccine yesterday this morning has a Headache wants to know if she can take ibuprophen. On 06Mar2021, the patient experienced headache. Outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, on 03Mar2021 as a SINGLE DOSE for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included ibuprofen (ADVIL) taken for an unspecified indication, start and stop dates were not reported. Patient reported that received the COVID-19 vaccination on Wednesday 03Mar2021. Saturday evening and Sunday (on06Mar2021 and 07Mar2021) had diarrhoea. It was reported that while there was a stomach bug passing around patient's family the prior week, patient was unsure if had the same bug or if it was from the vaccine, so reporting out of an abundance of caution. The outcome of the event was reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Muscular weakness
Clinical narrative: arm felt heavy and weak at the injected side; arm felt heavy and weak at the injected side; This is a spontaneous report from a non-contactable consumer (reported for daughter). A 27-years-old female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) administered via an unknown route on 06Mar2021 at 15:00 pm as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 06Mar2021 at 07:45pm, the patient complained arm felt heavy and weak at the injected side tonight but overall was doing well. The outcome of the events was unknown.  No follow-up attempts were possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite
Clinical narrative: She experienced no appetite; This is a spontaneous report received from a Pfizer Sponsored Program.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 03Mar2021 as 1st dose, single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included potassium taken for an unspecified indication, start and stop date were not reported. She also took some medications like water pill, heart pill and other pills. On Mar2021 after the 1st dose, the patient experienced she experienced no appetite. The seriousness of the event was reported as non-serious. The clinical outcome of the event was unknown.  Information on the lot/batch number has been requested.  Upon Follow-up on 11MAY2021: "This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected."
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: she developed a fever; This is a spontaneous report from a contactable consumer (Patient) via Pfizer Sponsored program.  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 05Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On an unspecified date (after second dose), patient developed a fever. The patient was asking if she can take Tylenol. The outcome of the event fever was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.